Eortc workshop on clinical trial methodology in older individuals with a diagnosis of solid tumors

Annals of Oncology

Volumn 22, Issue 8, 2011, Pages 1922-1926

  Pallis, A G ^a   Ring, A ^b   Fortpied, C ^c   Penninckx, B ^c   van Nes, M C ^d   Wedding, U ^e   vonMinckwitz, G ^f   Johnson, C D ^g   Wyld, L ^h   Timmer Bonte, A ⁱ   Bonnetain, F ^j   Repetto, L ^k   Aapro, M ^l   Luciani, A ^m   Wildiers, H ⁿ  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^b ROYAL SUSSEX COUNTY HOSPITAL   (United Kingdom)

^c EORTC DATA CENTER   (Belgium)

^d Centre Hospitalier Regional de La Citadelle   (Belgium)

^e FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^f GERMAN BREAST GROUP   (Germany)

^g UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^h UNIVERSITY OF SHEFFIELD   (United Kingdom)

ⁱ RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^j CENTRE GEORGES FRANÇOIS LECLERC   (France)

^k Istituto di Ricovero e Cura A Carattere Scientifico   (Italy)

^l CLINIQUE DE GENOLIER   (Switzerland)

^m SAN PAOLO HOSPITAL   (Italy)

ⁿ UNIVERSITY HOSPITALS LEUVEN   (Belgium)

more..

Author keywords

Clinical trials; EORTC workshop; Geriatric oncology; Solid tumors

Indexed keywords

AGE; AGING; ARTICLE; CANCER PATIENT; CLINICAL TRIAL (TOPIC); DRUG INDUSTRY; FUNCTIONAL STATUS; GERIATRIC ASSESSMENT; HUMAN; INDEPENDENCE; MEDICAL SOCIETY; POSTMARKETING SURVEILLANCE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SOLID TUMOR; TREATMENT PLANNING;

EID: 79960973060     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdq687     Document Type: Article

References (28)

1. Giannakouris K. Population and Social Conditions. Ageing Characterises the Demographic Perspectives of the European Societies. Luxemburg: Eurostat Statistics in Focus 2008; 72.
2. Yancik R. Cancer burden in the aged: an epidemiologic and demographic overview. Cancer 1997; 80: 1273-1283.
3. Jemal A, Siegel R, Ward E et al. Cancer statistics, 2009. CA Cancer J Clin 2009; 59: 225-249.
4. Hutchins LF, Unger JM, Crowley JJ et al. Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med 1999; 341: 2061-2067.
5. Husain LS, Collins K, Reed M et al. Choices in cancer treatment: a qualitative study of the older women's (>70 years) perspective. Psychooncology 2008; 17: 410-416.
6. Overcash JA. Using narrative research to understand the quality of life of older women with breast cancer. Oncol Nurs Forum 2004; 31: 1153-1159.
7. Balducci L. Geriatric oncology: challenges for the new century. Eur J Cancer 2000; 36: 1741-1754.
8. Pallis AG, Wedding U, Lacombe D et al. Questionnaires and instruments for a multidimensional assessment of the older cancer patient: what clinicians need to know? Eur J Cancer 2010; 46: 1019-1025.
9. Soubeyran P, Bellera CA, Gregoire F et al. Validation of a screening test for elderly patients in oncology. J Clin Oncol 2008; 26: (Abstr 20568).
10. Lawton MP. Scales to measure competence in everyday activities. Psychopharmacol Bull 1988; 24: 609-614.
11. Charlson ME, Pompei P, Ales KL et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-383.
12. Maione P, Perrone F, Gallo C et al. Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the elderly study. J Clin Oncol 2005; 23: 6865-6872.
13. Wedding U, Honeker F, Rettig K et al. Comprehensive geriatric assessment (CGA) in elderly patients with hematological neoplasia: CGA and not age predicts mortality-results from IN-GHOAdvPSSym.-1.C226-registry. Blood 2009; 112: (ASH Annual Meeting Abstracts).
14. Wedding U, Rohrig B, Klippstein A et al. Impairment in functional status and survival in patients with acute myeloid leukaemia. J Cancer Res Clin Oncol 2006; 132: 665-671.
15. Freyer G, Geay JF, Touzet S et al. Comprehensive geriatric assessment predicts tolerance to chemotherapy and survival in elderly patients with advanced ovarian carcinoma: a GINECO study. Ann Oncol 2005; 16: 1795-1800.
16. Audisio RA, Ramesh H, Longo WE et al. Preoperative assessment of surgical risk in oncogeriatric patients. Oncologist 2005; 10: 262-268.
17. Balducci L, Extermann M. Management of cancer in the older person: a practical approach. Oncologist 2000; 5: 224-237.
18. Extermann M, Overcash J, Lyman GH et al. Comorbidity and functional status are independent in older cancer patients. J Clin Oncol 1998; 16: 1582-1587.
19. Frasci G, Lorusso V, Panza N et al. Gemcitabine plus vinorelbine versus vinorelbine alone in elderly patients with advanced non-small-cell lung cancer. J Clin Oncol 2000; 18: 2529-2536.
20. Firat S, Byhardt RW, Gore E. Comorbidity and Karnofksy performance score are independent prognostic factors in stage III non-small-cell lung cancer: an institutional analysis of patients treated on four RTOG studies. Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 2002; 54: 357-364.
21. Firat S, Bousamra M, Gore E et al. Comorbidity and KPS are independent prognostic factors in stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2002; 52: 1047-1057.
22. Piccirillo JF, Tierney RM, Costas I et al. Prognostic importance of comorbidity in a hospital-based cancer registry. JAMA 2004; 291: 2441-2447.
23. Satariano WA, Ragland DR. The effect of comorbidity on 3-year survival of women with primary breast cancer. Ann Intern Med 1994; 120: 104-110.
24. Kastner C, Armitage J, Kimble A et al. The Charlson comorbidity score: a superior comorbidity assessment tool for the prostate cancer multidisciplinary meeting. Prostate Cancer Prostatic Dis 2006; 9: 270-274.
25. Wedding U, Rohrig B, Klippstein A et al. Age, severe comorbidity and functional impairment independently contribute to poor survival in cancer patients. J Cancer Res Clin Oncol 2007; 133: 945-950.
26. Nagel G, Wedding U, Rohrig B et al. The impact of comorbidity on the survival of postmenopausal women with breast cancer. J Cancer Res Clin Oncol 2004; 130: 664-670.
27. Steyerberg EW, Neville BA, Koppert LB et al. Surgical mortality in patients with esophageal cancer: development and validation of a simple risk score. J Clin Oncol 2006; 24: 4277-4284.
28. Birim O, Kappetein AP, van Klaveren RJ et al. Prognostic factors in non-small cell lung cancer surgery. Eur J Surg Oncol 2006; 32: 12-23.